Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)
South Korea · Delayed Price · Currency is KRW 185,200
-900 (-0.48%)
Aug 14, 2025, 3:30 PM KST
Sam Chun Dang Pharm. Market Cap
Sam Chun Dang Pharm. has a market cap or net worth of 4.31 trillion as of August 15, 2025. Its market cap has increased by 0.14% in one year.
Market Cap
4.31T
Enterprise Value
4.31T
Revenue
213.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
185,200.00
Market Cap Chart
Since September 11, 2001, Sam Chun Dang Pharm.'s market cap has increased from 3.32B to 4.31T, an increase of 129,637.51%. That is a compound annual growth rate of 34.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 4,307.28B | 24.71% |
| Dec 30, 2024 | 3,453.73B | 96.33% |
| Dec 28, 2023 | 1,759.15B | 82.00% |
| Dec 29, 2022 | 966.58B | 1.04% |
| Dec 30, 2021 | 956.65B | -47.20% |
| Dec 30, 2020 | 1,811.79B | 137.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.52T |
| Celltrion | 38.58T |
| ALTEOGEN | 23.35T |
| Yuhan | 8,561.74B |
| Peptron | 8,235.61B |
| SK Biopharmaceuticals | 7,878.31B |
| PharmaResearch | 7,106.52B |
| LigaChem Biosciences | 5,666.20B |